Prevalence of cardiac diastolic dysfunction in HIV-infected patients: Results of the HIV-HEART study

HIV Clinical Trials

Volumn 11, Issue 3, 2010, Pages 156-162

  Reinsch, Nico ^a   Neuhaus, Kathrin ^a   Esser, Stefan ^b   Potthoff, Anja ^c   Hower, Martin H ^d   Brockmeyer, Norbert ^c   Erbel, Raimund ^a   Neumann, Till ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d KLINIKUM DORTMUND   (Germany)

Author keywords

diastolic dysfunction; HIV infection; prevalence

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CLINICAL TRIAL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; GERMANY; HEART FAILURE, DIASTOLIC; HIV INFECTIONS; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR;

ANTI-HIV AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GERMANY; HEART FAILURE, DIASTOLIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 77956049613     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1103-156     Document Type: Article

References (29)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
2. Koutkia P, Grinspoon S. HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Ann Rev Med. 2004;55:303-317.
3. Mocroft A, Ledergerber B, Katlama C, et al; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22-29.
4. Friis-Møller N, Weber R, Reiss P, et al; D:A:D study group. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study. AIDS. 2003;17:1179-1193.
5. D:A:D Study Group; Friis-Møller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-1735.
6. Nayak G, Ferguson M, Tribble DR, Porter CK, Rapena R, Marchicelli M, Decker CF. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS. 2009;23:231-238.
7. Kuznetsova T, Herbots L, López B, et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2:105-112.
8. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289.
9. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-327.
10. Redfi eld MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheller RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J Am Med Assoc. 2003;289:194-202.
11. Rusconi C, Sabatini T, Faggiano P, et al. Prevalence of isolated left ventricular diastolic dysfunction in hypertension as assessed by combined transmitral and pulmonary vein fl ow Doppler study. Am J Cardiol. 2001;87:357-360.
12. Neumann T, Esser S, Potthoff A, et al. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res. 2007;12:243-248.
13. Otto C. Transthoracic views, normal anatomy, and fl ow patterns. In: Textbook of Clinical Echocardiography. 3rd ed. Philadelphia: Elsevier Saunders; 2004.
14. Cheitlin MD, Armstrong WF, Aurigemma GP, et al; ACC; AHA; ASE. ACC/AHA/ASE 2003. Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003;16:1091-1110.
15. Erbel R, Schweizer P, Henn G, Meyer J, Effert S. Apical two-dimensional echocardiography: normal values for single- and bi-plane determination of left ventricular volume and ejection fraction. Deutsche Medizinische Wochenschrift. 1982;107:1872-1877.
16. Lang RM, Bierig M, Devereux RB, et al; Chamber Quantifi cation Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifi cation Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
17. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J. 1998;19:990-1003.
18. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005;3:9.
19. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: Diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387-1393.
20. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J. 2003;24:320-328.
21. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: Causal mechanisms and treatment. Circulation. 2002;105:1503-1508.
22. Annonu AK, Fattah AA, Mokhtar MS, Ghareeb S, Elhendy A. Left ventricular systolic and diastolic functional abnormalities in asymptomatic patients with non-insulindependent diabetes mellitus. J Am Soc Echocardiogr. 2001;14:885-891.
23. D:A:D Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration. Lancet. 2008;371:1417-1426.
24. Schuster I, Thöni GJ, Edérhy S, et al. Subclinical cardiac abnormalities in human immunodeficiency virusinfected men receiving antiretroviral therapy. Am J Cardiol. 2008;101:1213-1217.
25. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New Engl J Med. 2005;352:48-62.
26. Meng Q, Lima JA, Lai H, et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defi c Syndr. 2002;30:306-310.
27. Strategies for Management of Antiretroviral Therapy (SMART) Study Group; El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral therapy. N Engl J Med. 2006;355:2283-2296.
28. Torriani FJ, Komarow L, Parker RA, et al. Endothelial function in human immunodefi ciency virus-infected antiretroviral- naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008;52:569-576.
29. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodefi ciency virus infection. Am J Cardiol. 1993;71:955-958.